These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 17852860)

  • 1. Relationship between fecal lactoferrin and inflammatory bowel disease.
    Dai J; Liu WZ; Zhao YP; Hu YB; Ge ZZ
    Scand J Gastroenterol; 2007 Dec; 42(12):1440-4. PubMed ID: 17852860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fecal lactoferrin is a sensitive and specific marker in identifying intestinal inflammation.
    Kane SV; Sandborn WJ; Rufo PA; Zholudev A; Boone J; Lyerly D; Camilleri M; Hanauer SB
    Am J Gastroenterol; 2003 Jun; 98(6):1309-14. PubMed ID: 12818275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices.
    Langhorst J; Elsenbruch S; Koelzer J; Rueffer A; Michalsen A; Dobos GJ
    Am J Gastroenterol; 2008 Jan; 103(1):162-9. PubMed ID: 17916108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fecal lactoferrin is a sensitive and specific marker of disease activity in children and young adults with inflammatory bowel disease.
    Walker TR; Land ML; Kartashov A; Saslowsky TM; Lyerly DM; Boone JH; Rufo PA
    J Pediatr Gastroenterol Nutr; 2007 Apr; 44(4):414-22. PubMed ID: 17414136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated human beta-defensin-2 levels indicate an activation of the innate immune system in patients with irritable bowel syndrome.
    Langhorst J; Junge A; Rueffer A; Wehkamp J; Foell D; Michalsen A; Musial F; Dobos GJ
    Am J Gastroenterol; 2009 Feb; 104(2):404-10. PubMed ID: 19174795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accuracy of four fecal assays in the diagnosis of colitis.
    Schoepfer AM; Trummler M; Seeholzer P; Criblez DH; Seibold F
    Dis Colon Rectum; 2007 Oct; 50(10):1697-706. PubMed ID: 17762964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fecal lactoferrin as a marker for disease activity in inflammatory bowel disease: comparison with other neutrophil-derived proteins.
    Sugi K; Saitoh O; Hirata I; Katsu K
    Am J Gastroenterol; 1996 May; 91(5):927-34. PubMed ID: 8633583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Significance of fecal lactoferrin in evaluation of disease activity in ulcerative colitis].
    Xiang JY; Ouyang Q; Li GD
    Zhonghua Yi Xue Za Zhi; 2007 Aug; 87(32):2262-4. PubMed ID: 18001547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fecal excretion of alpha 2-macroglobulin: a novel marker for disease activity in patients with inflammatory bowel disease.
    Becker K; Niederau C; Frieling T
    Z Gastroenterol; 1999 Jul; 37(7):597-605. PubMed ID: 10458008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lactoferrin in whole gut lavage fluid as a marker for disease activity in inflammatory bowel disease: comparison with other neutrophil-derived proteins.
    Kayazawa M; Saitoh O; Kojima K; Nakagawa K; Tanaka S; Tabata K; Matsuse R; Uchida K; Hoshimoto M; Hirata I; Katsu K
    Am J Gastroenterol; 2002 Feb; 97(2):360-9. PubMed ID: 11866274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fecal leukocyte proteins in inflammatory bowel disease and irritable bowel syndrome.
    Silberer H; Küppers B; Mickisch O; Baniewicz W; Drescher M; Traber L; Kempf A; Schmidt-Gayk H
    Clin Lab; 2005; 51(3-4):117-26. PubMed ID: 15819166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fecal eosinophil granule-derived proteins reflect disease activity in inflammatory bowel disease.
    Saitoh O; Kojima K; Sugi K; Matsuse R; Uchida K; Tabata K; Nakagawa K; Kayazawa M; Hirata I; Katsu K
    Am J Gastroenterol; 1999 Dec; 94(12):3513-20. PubMed ID: 10606313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fecal pyruvate kinase: a potential new marker for intestinal inflammation in children with inflammatory bowel disease.
    Czub E; Herzig KH; Szaflarska-Popawska A; Kiehne K; Socha P; Woś H; Kamińska B; Błaszczyński M; Cichy W; Bała G; Brodzicki J; Grzybowska-Chlebowczyk U; Walkowiak J
    Scand J Gastroenterol; 2007 Oct; 42(10):1147-50. PubMed ID: 17852864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Faecal lactoferrin--a novel test to differentiate between the irritable and inflamed bowel?
    Sidhu R; Wilson P; Wright A; Yau CW; D'Cruz FA; Foye L; Morley S; Lobo AJ; McAlindon ME; Sanders DS
    Aliment Pharmacol Ther; 2010 Jun; 31(12):1365-70. PubMed ID: 20331581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fecal calprotectin correlates more closely with the Simple Endoscopic Score for Crohn's disease (SES-CD) than CRP, blood leukocytes, and the CDAI.
    Schoepfer AM; Beglinger C; Straumann A; Trummler M; Vavricka SR; Bruegger LE; Seibold F
    Am J Gastroenterol; 2010 Jan; 105(1):162-9. PubMed ID: 19755969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Faecal S100A12 as a non-invasive marker distinguishing inflammatory bowel disease from irritable bowel syndrome.
    Kaiser T; Langhorst J; Wittkowski H; Becker K; Friedrich AW; Rueffer A; Dobos GJ; Roth J; Foell D
    Gut; 2007 Dec; 56(12):1706-13. PubMed ID: 17675327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fecal calprotectin and lactoferrin as noninvasive markers of pediatric inflammatory bowel disease.
    Joishy M; Davies I; Ahmed M; Wassel J; Davies K; Sayers A; Jenkins H
    J Pediatr Gastroenterol Nutr; 2009 Jan; 48(1):48-54. PubMed ID: 19172123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fecal calprotectin remains high during glucocorticoid therapy in children with inflammatory bowel disease.
    Kolho KL; Raivio T; Lindahl H; Savilahti E
    Scand J Gastroenterol; 2006 Jun; 41(6):720-5. PubMed ID: 16716972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phagocyte-specific S100 proteins are released from affected mucosa and promote immune responses during inflammatory bowel disease.
    Foell D; Wittkowski H; Ren Z; Turton J; Pang G; Daebritz J; Ehrchen J; Heidemann J; Borody T; Roth J; Clancy R
    J Pathol; 2008 Oct; 216(2):183-92. PubMed ID: 18729068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fecal lactoferrin, a marker of intestinal inflammation in children with inflammatory bowel disease.
    Borkowska A; Liberek A; Łuczak G; Jankowska A; Plata-Nazar K; Korzon M; Kamińska B
    Acta Biochim Pol; 2015; 62(3):541-5. PubMed ID: 26339799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.